Diabetes Genetics Section, Division of Genetics, Clinical Hospital of the University of Buenos Aires, Buenos Aires (C1120AAR), Argentina.
Eur J Endocrinol. 2011 Apr;164(4):559-67. doi: 10.1530/EJE-10-1039. Epub 2011 Jan 24.
The metabolic syndrome (MS) is a cluster of cardiometabolic factors, which predisposes to diabetes and cardiovascular disease (CVD). Early detection of high-risk individuals for MS using accurate measures of insulin resistance (IR) could improve detection and prevention of CVD and diabetes. The aim of this study was to explore the ability of lipid accumulation product (LAP), compared with traditional measures of IR, to identify MS.
In total, 768 Spanish adults were recruited. MS was assessed using the revised criteria of National Cholesterol Education Program/Adult Treatment Panel III (NCEP/ATP III) and International Diabetes Federation (IDF). Measures of IR such as homeostasis model assessment of IR and LAP, an index of lipid accumulation based on a combination of waist circumference and serum triglycerides, were calculated. Receiver operating characteristic analysis was performed in order to detect the parameter with the best predictive capability for MS.
The prevalence of MS-NCEP/ATP III and MS-IDF was 15.1 and 20.5% for men respectively, and 15.4 and 17.5% for women. LAP showed the highest diagnostic accuracy for MS-NCEP/ATP III (area under the curve 0.91 and 0.90 among males and females) and MS-IDF (0.88 for both males and females). This was confirmed by internal validation using 20 000 bootstrap samples. Among males and females, different LAP cut-off values exhibited high sensitivity (78-85%) and specificity (78-85%) for MS-NCEP/ATP III and MS-IDF identification with elevated efficiency (proportion of positives and negatives classified correctly by the test=78-85%). When the sample was stratified according to decades of life, LAP exhibited a slightly lower performance among women than men, especially for MS-IDF detection.
In non-diabetic adults LAP has a strong and reliable diagnostic accuracy for MS-IDF and, especially, MS-NCEP/ATP III among females and, in particular, among males from Spain.
代谢综合征(MS)是一组心血管代谢因素,易导致糖尿病和心血管疾病(CVD)。使用胰岛素抵抗(IR)的准确测量方法对 MS 的高危个体进行早期检测,可提高 CVD 和糖尿病的检测和预防效果。本研究旨在探讨脂质堆积产物(LAP)与传统的 IR 测量方法相比,在识别 MS 方面的能力。
共招募了 768 名西班牙成年人。使用修订后的国家胆固醇教育计划/成人治疗小组 III(NCEP/ATP III)和国际糖尿病联盟(IDF)标准评估 MS。计算了 IR 的测量指标,如稳态模型评估的 IR 和 LAP,这是一种基于腰围和血清甘油三酯组合的脂质堆积指数。进行了受试者工作特征分析,以检测对 MS 具有最佳预测能力的参数。
MS-NCEP/ATP III 和 MS-IDF 的患病率分别为男性 15.1%和 20.5%,女性 15.4%和 17.5%。LAP 对 MS-NCEP/ATP III(男性和女性的曲线下面积分别为 0.91 和 0.90)和 MS-IDF(男性和女性均为 0.88)的诊断准确性最高。这通过使用 20000 个 bootstrap 样本进行内部验证得到了证实。在男性和女性中,不同的 LAP 截断值对 MS-NCEP/ATP III 和 MS-IDF 的识别具有较高的敏感性(78-85%)和特异性(78-85%),效率较高(测试正确分类的阳性和阴性比例=78-85%)。当根据生命的几十年对样本进行分层时,LAP 在女性中的表现略低于男性,尤其是在检测 MS-IDF 时。
在非糖尿病成年人中,LAP 对 MS-IDF 具有很强且可靠的诊断准确性,尤其是对女性和特别是西班牙男性的 MS-NCEP/ATP III。